文献速递哮喘

重症哮喘急性加重的预测路径:贝叶斯网络分析

Prediction Pathway for Severe Asthma Exacerbations: A Bayesian Network Analysis.
PubMed 文献 · Chest · 2025-05-19

该研究基于重症哮喘注册库(2017-2021年)中6814例未使用生物制剂的成人重症哮喘患者,结合专家知识与机器学习构建贝叶斯网络,揭示血嗜酸性粒细胞计数、呼出气一氧化氮(FeNO)和FEV1直接介导既往与未来重症急性加重之间的风险转换,慢性鼻窦炎通过影响上述指标间接起作用,大环内酯类药物使用则独立影响加重史。

要点

  • 血嗜酸性粒细胞、FeNO和FEV1是重症急性加重风险转换的直接预测因子。
  • 慢性鼻窦炎通过影响上述直接预测因子间接影响未来加重风险。
  • 大环内酯类药物使用独立通过加重史影响未来重症急性加重。

核心结论

  • 研究识别出重症哮喘急性加重的关键预测路径,涉及慢性鼻窦炎对风险转换直接预测因子的影响以及大环内酯类药物使用。

研究设计与样本

  • 研究基于重症哮喘注册库(2017-2021年)纳入6814例年龄≥18岁、未使用生物制剂的重症哮喘患者。
  • 采用贝叶斯网络结合专家知识与机器学习算法构建预测路径,并进行内部验证。

主要发现

  • 血嗜酸性粒细胞计数、呼出气一氧化氮水平和FEV1直接影响既往与未来重症急性加重之间的转换。
  • 慢性鼻窦炎通过直接影响血嗜酸性粒细胞计数、呼出气一氧化氮和FEV1%预计值间接影响该转换。
  • 大环内酯类药物使用独立影响加重史,进而影响未来重症哮喘急性加重。
  • 模型在10折交叉验证和留一国家交叉验证中区分度中等,在训练-测试数据中校准度高。

临床怎么用

  • 研究结果支持在重症哮喘治疗中开展共享临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate risk prediction of exacerbations is pivotal in severe asthma management. Multiple risk factors are at play, but the pathway of risk prediction remains unclear. RESEARCH QUESTION: How do the interplays of clinically relevant predictors lead to severe exacerbations in patients with severe asthma? STUDY DESIGN AND METHODS: Patients with severe asthma (n = 6,814, aged ≥ 18 years), biologic naive, were identified from the Severe Asthma Registry (2017-2021). Relevant predictors covered demographics, lung function, inflammation biomarkers, health care use, medications, exacerbation history, and comorbidities. A Bayesian network, representing the prediction process of severe exacerbations, was obtained by combining expert knowledge and machine learning algorithms. Internal validation was performed. The proposed influence diagram integrated decision and utility nodes into the prediction pathway. RESULTS: The Bayesian network analysis revealed that blood eosinophil count, fractional exhaled nitric oxide level, and FEV1 directly influenced the transition between prior and future severe exacerbations. The presence of chronic rhinosinusitis indirectly affected such transition by directly influencing blood eosinophil count, fractional exhaled nitric oxide, and % predicted FEV1. Macrolide use independently affected history of exacerbations to influence future severe asthma exacerbations. Model discrimination was moderate in 10-fold cross-validation and leave-1-country-out cross-validation, and model calibration was high in train-test data. INTERPRETATION: This study identified an essential prediction pathway of severe exacerbation, which involves the influence of chronic rhinosinusitis on the immediate predictors of risk transition from current to future severe asthma exacerbations. Macrolide use was another essential prediction pathway identified. The findings support shared clinical decision-making in severe asthma treatment.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Yadav, Chakraborty, Price, et al. Prediction Pathway for Severe Asthma Exacerbations: A Bayesian Network Analysis. Chest. 2025. PMID: 40398558. doi:10.1016/j.chest.2025.04.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。